Glutathione (GSH)
Glutathione (GSH) is the most abundant intracellular non-protein thiol, synthesised endogenously from glycine, cysteine, and glutamate via the γ-glutamylcysteine synthetase/glutathione synthetase pathway. As a tripeptide (γ-Glu-Cys-Gly), GSH constitutes the principal cellular antioxidant defence system and serves as essential cofactor for glutathione peroxidases (GPx), glutathione S-transferases (GST), and glutaredoxins. Research interest spans redox biology, hepatic detoxification, immune function, and protein quality control through reversible glutathionylation.
Mechanism of Action
The catalytic core of GSH's antioxidant activity resides in the thiol group (-SH) of its cysteine residue (pKa ~9.2). At physiological pH, a significant fraction exists as the thiolate anion (GS⁻), which is a potent nucleophile capable of directly reducing reactive oxygen species (ROS) and reactive nitrogen species (RNS) through electron donation. This direct scavenging produces glutathione disulfide (GSSG), regenerated to GSH by glutathione reductase (GR) using NADPH as the electron donor — forming the GSH/GSSG redox cycle that is central to cellular antioxidant capacity.
As a cofactor for glutathione peroxidases (GPx1–8), GSH facilitates the two-electron reduction of hydrogen peroxide and lipid hydroperoxides to water and the corresponding alcohol, respectively. This reaction is particularly critical in erythrocytes and hepatocytes where peroxide flux is high. Glutathione S-transferases (GSTs — alpha, mu, pi, theta superfamilies) exploit GSH's nucleophilicity to conjugate it to electrophilic metabolites, including products of Phase I cytochrome P450 oxidation, forming glutathione conjugates that are exported by MRP transporters for biliary or renal elimination.
Beyond direct antioxidant catalysis, GSH participates in reversible protein glutathionylation — the formation of mixed disulfides between GSH and cysteine residues of target proteins. This post-translational modification modulates the activity of transcription factors (NF-κB, Nrf2), metabolic enzymes, and ion channels under oxidative stress, serving both protective (preventing irreversible cysteine oxidation) and regulatory (redox signalling) functions.
Selected Research Findings
- Exogenous GSH administration in acetaminophen (APAP)-challenged rodent hepatocyte models significantly attenuated APAP-induced centrilobular necrosis by replenishing hepatic GSH stores depleted by NAPQI conjugation, restoring GPx activity and reducing serum ALT/AST markers of hepatocellular injury. Preclinical hepatotoxicity models
- In a 6-month human randomised controlled trial (Richie et al., Eur J Nutr 2015), oral glutathione (250 or 1,000 mg/day) increased blood GSH levels at both doses, with 30–35% increases in erythrocytes, plasma and lymphocytes in the high-dose group, and lowered the oxidised-to-reduced glutathione ratio — demonstrating meaningful systemic bioavailability of the tripeptide despite theoretical susceptibility to intestinal peptidase degradation. Richie et al., Eur J Nutr 2015
- In HBV/HCV-associated chronic liver disease cohort studies, parenteral GSH supplementation correlated with improved hepatic antioxidant enzyme profiles (GR, GPx, catalase) and reduced malondialdehyde (MDA) as a lipid peroxidation marker, suggesting restoration of hepatic redox homeostasis in the context of elevated oxidative stress. Hepatology literature, liver disease models
- GSH/GSSG ratio analyses in peripheral blood mononuclear cells (PBMCs) from exercise research protocols indicate that high-intensity oxidative stress transiently suppresses the GSH/GSSG ratio; exogenous GSH supplementation in murine models accelerated ratio recovery, preserving mitochondrial membrane potential and limiting exercise-induced apoptotic signalling. Exercise physiology / redox biology models
- Nrf2 pathway studies demonstrate that GSH depletion (via BSO, L-buthionine sulfoximine) activates Nrf2-Keap1 dissociation, upregulating ARE-driven expression of GCL, GSS, GR, and GPx — revealing the feedback regulatory loop between GSH availability and its biosynthetic machinery. Nrf2 / ARE pathway research
Citations last reviewed: 1 October 2026
As Supplied by BasedPeps
Researcher FAQ
What is the primary redox mechanism of glutathione?
GSH donates an electron from its cysteine thiol to neutralise reactive oxygen species, forming glutathione disulfide (GSSG). Glutathione reductase uses NADPH to regenerate GSH, sustaining the cycle. This GSH/GSSG redox couple is the principal intracellular antioxidant buffer studied across cell biology models.
How does glutathione support Phase II detoxification?
Glutathione S-transferases (GSTs) catalyse conjugation of GSH to electrophilic substrates — including reactive metabolites generated by Phase I CYP450 oxidation — forming water-soluble glutathione conjugates. These are actively transported by MRP (ABCC) family exporters for biliary or renal elimination, completing Phase II detoxification.
What distinguishes reduced GSH from oxidised GSSG in research contexts?
GSH is the active reduced form with a free thiol capable of ROS scavenging, GPx cofactor activity, and GST conjugation. GSSG is the oxidised homodimer lacking these activities. The GSH/GSSG ratio (typically >10:1 in healthy cells) is a widely used research marker of cellular oxidative stress status.
What is protein glutathionylation and why is it relevant to research?
Glutathionylation refers to the formation of a reversible mixed disulfide between a protein cysteine and GSH under oxidative conditions. This modification protects critical cysteine residues from irreversible oxidation and modulates activity of proteins including NF-κB, protein tyrosine phosphatases, and mitochondrial complex I — making it a key mechanism for studying redox signalling.
How is this glutathione supplied for research?
Supplied as lyophilised reduced L-glutathione (GSH) powder, ≥99% purity by HPLC, in 600 mg or 1500 mg quantities. For in-vitro cell culture and in-vivo preclinical research use only. Not intended for human administration.
Research-Grade Glutathione (GSH)
≥99% purity, lyophilised reduced L-glutathione. Available in 600 mg and 1500 mg formats for antioxidant and redox biology research.
View Product Details →